PAX5 and acute lymphoblastic leukemia: Fedullo et al. once investigated the copy number aberrations (CNA) in 116 de novo Ph+ ALL patients and revealed that simultaneous deletions of IKZF1 plus CDKN2A/B and/or PAX5 conferred a significantly worse DFS [27].